CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZNCF

Durvalumab (MEDI4736)

Phase 3
ASTRAZENECA PLC (AZNCF)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Non Small Cell Lung Carcinoma NSCLC

View Full Landscape
Drug Information

Target Indication

Non Small Cell Lung Carcinoma NSCLC

Clinical Trial

NCT03003962

Last updated: 3/12/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.